The Australian Women’s Weekly New Zealand Edition — May 2017

PZR0190_WW_MAY

Menopause.

Why is it so hard to say?

Start a conversation about Menopause today.

There are some experiences in life that most

women will go through.

Puberty. Childbirth. Menopause.

They’re all normal and natural.

So why does that last one feel so different?

Because we don’t talk about it.

We avoid it.

It’s time to start talking about hot fl ushes, night

sweats and other troublesome symptoms.

Duavive is a new therapy that may help to relieve

these menopausal issues, so talk to your doctor

today and get the conversation started.^1

Visit http://www.themword.co.nz to hear real Kiwi women discuss Menopause.

Talk to your doctor about a plan that’s right for you, which may include Duavive.

References: 1. Duavive Data Sheet.

DUAVIVEDUAVIVE (conjugated estrogens/bazedoxifene) is an unfunded prescription medicine for the treatment of estrogen defi® (CONJUGATED ESTROGENS/BAZEDOXIFENE, 0.45 mg/20 mg) MODIFIED-RELEASE TABLETS (^) ciency symptoms. Use in postmenopausal women with a uterus (12
months post last menses) where progestin-containing therapy is not appropriate. There is limited experience in women older thanYou will need to pay for this medicine and normal doctor’s fees apply. DUAVIVE has risks and benefi ts. Women should discuss treatment with DUAVIVE with their doctor as there are certain 65 years.
situations where DUAVIVE should not be used and there are also important precautions with this medicine.Do not take DUAVIVE if you have an allergy to conjugated estrogens, bazedoxifene or any of the other ingredients in the tablet; (^) have, or have had, breast cancer or estrogen-dependent cancers;
unexplained vaginal bleeding or untreated excessive thickening of the uterus (endometrial hyperplasia); a blood clot in a vein clots in the arteries, such as a heart attack, stroke or angina; liver disease; porphyria. DUAVIVE is for postmenopausal women (thrombosis); a blood clotting disorder; disease caused by blood only. Do not take it if you are pregnant, think you might become
pregnant or are breast feeding. Caution is needed if you have: fi broids, endometriosis or endometrial hyperplasia; increased risk of developing blood clots or getting an estrogen-sensitive cancer; high blood pressure; a liver
disorder; diabetes; gallstones; migraine or severe headaches; systemic lupus erythematosus; seizures; asthma; a disease affectiof fat (triglycerides) in your blood; fl uid retention. ng the eardrum and hearing known as otosclerosis; a high level
Common side effects include abdominal pain (stomach ache), muscle spasms, constipation, diarrhoea, nausea and thrush (vaginal yUse strictly as directed. Consult your doctor to see if DUAVIVE is right for you. east infection). If you have any side effects see your doctor.
Contains 0.45 mg conjugated estrogens and bazedoxifene acetate equivalent to 20 mg bazedoxifene. Further information on DUAVIVE is available from http://www.medsafe.govt.nz or Pfi zer New Zealand Limited, Auckland, w w w.pfi zer.co.nz, Ph. 0800 736 363.
PfiDuavive zer New Zealand Limited, Level 1, Suite 1.4, Building B, 8 Nugent St, Grafton, Auckland 1023. V11116. PP-DUA-NZL-0006 TAPS NA ® is a Registered Trademark. © Pfi zer 2017. 8824 02/17 PZR0204.